Skip to main content

Outcomes of multi-drug resistant tuberculosis (MDR-TB) among a cohort of South African patients with high HIV prevalence.

Publication ,  Journal Article
Farley, JE; Ram, M; Pan, W; Waldman, S; Cassell, GH; Chaisson, RE; Weyer, K; Lancaster, J; Van der Walt, M
Published in: PloS one
January 2011

Multidrug-resistant tuberculosis (MDR-TB) is a major clinical challenge, particularly in patients with human immunodeficiency virus (HIV) co-infection. MDR-TB treatment is increasingly available, but outcomes have not been well characterized. South Africa has provided MDR-TB treatment for a decade, and we evaluated outcomes by HIV status for patients enrolled between 2000 and 2004 prior to anti-retroviral access.We assessed treatment outcomes in a prospective cohort of patients with MDR-TB from eight provincial programs providing second line drugs. World Health Organization definitions were used. Results were stratified by HIV status.Seven hundred fifty seven patients with known HIV status were included in the final analysis, and HIV infection was documented in 287 (38%). Overall, 348 patients (46.0%) were successfully treated, 74 (9.8%) failed therapy, 177 (23.4%) died and 158 (20.9%) defaulted. Patients with HIV were slightly younger and less likely to be male compared to HIV negative patients. Patients with HIV were less likely to have a successful treatment outcome (40.0 vs. 49.6; P<0.05) and more likely to die (35.2 vs. 16.2; P<0.0001). In a competing risk survival analysis, patients with HIV had a higher hazard of death (HR: 2.33, P<0.0001). Low baseline weight (less than 45 kg and less than 60 kg) was also associated with a higher hazard of death (HR: 2.52, P<0.0001; and HR: 1.50, P<0.0001, respectively, compared to weight greater than 60 kg). Weight less than 45 kg had higher risk of failure (HR: 3.58, P<0.01). Any change in treatment regimen was associated with a higher hazard of default (HR: 2.86; 95% CI 1.55-5.29, P<0.001) and a lower hazard of death (HR: 0.63, P<0.05).In this MDR-TB treatment program patients with HIV infection and low weight had higher hazards of death. Overall treatment outcomes were poor. Efforts to improve treatment for MDR-TB are urgently needed.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

PloS one

DOI

EISSN

1932-6203

ISSN

1932-6203

Publication Date

January 2011

Volume

6

Issue

7

Start / End Page

e20436

Related Subject Headings

  • Young Adult
  • Tuberculosis, Multidrug-Resistant
  • Treatment Outcome
  • South Africa
  • Prevalence
  • Middle Aged
  • Male
  • Humans
  • HIV Infections
  • General Science & Technology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Farley, J. E., Ram, M., Pan, W., Waldman, S., Cassell, G. H., Chaisson, R. E., … Van der Walt, M. (2011). Outcomes of multi-drug resistant tuberculosis (MDR-TB) among a cohort of South African patients with high HIV prevalence. PloS One, 6(7), e20436. https://doi.org/10.1371/journal.pone.0020436
Farley, Jason E., Malathi Ram, William Pan, Stacie Waldman, Gail H. Cassell, Richard E. Chaisson, Karin Weyer, Joey Lancaster, and Martie Van der Walt. “Outcomes of multi-drug resistant tuberculosis (MDR-TB) among a cohort of South African patients with high HIV prevalence.PloS One 6, no. 7 (January 2011): e20436. https://doi.org/10.1371/journal.pone.0020436.
Farley JE, Ram M, Pan W, Waldman S, Cassell GH, Chaisson RE, et al. Outcomes of multi-drug resistant tuberculosis (MDR-TB) among a cohort of South African patients with high HIV prevalence. PloS one. 2011 Jan;6(7):e20436.
Farley, Jason E., et al. “Outcomes of multi-drug resistant tuberculosis (MDR-TB) among a cohort of South African patients with high HIV prevalence.PloS One, vol. 6, no. 7, Jan. 2011, p. e20436. Epmc, doi:10.1371/journal.pone.0020436.
Farley JE, Ram M, Pan W, Waldman S, Cassell GH, Chaisson RE, Weyer K, Lancaster J, Van der Walt M. Outcomes of multi-drug resistant tuberculosis (MDR-TB) among a cohort of South African patients with high HIV prevalence. PloS one. 2011 Jan;6(7):e20436.

Published In

PloS one

DOI

EISSN

1932-6203

ISSN

1932-6203

Publication Date

January 2011

Volume

6

Issue

7

Start / End Page

e20436

Related Subject Headings

  • Young Adult
  • Tuberculosis, Multidrug-Resistant
  • Treatment Outcome
  • South Africa
  • Prevalence
  • Middle Aged
  • Male
  • Humans
  • HIV Infections
  • General Science & Technology